Indian vaccine co had adverse event; experts seek more transparency
Hyderabad-based Bharat Biotech’s potential Covid-19 vaccine reported a serious adverse event during clinical trials in August, even as it’s now initiated the Phase 3 stage of the study. The adverse event occurred in a 35-year old participant with no comorbidities, who was part of Phase 1 trials in August, investigators monitoring the study confirmed to TOI on condition of anonymity.
You Might Like
💡 newsR Knowledge: Other News Mentions
Jharkhand Police: ₹ 35 lakh as fine from masses violating Covid norms | Oneindia News
Credit: Oneindia Duration: 03:39Published
Covaxin effectively neutralises all key emerging variants, says study published in Oxford journalIndigenous Covid-19 vaccine Covaxin has been able to neutralise all key emerging variants, including the double mutant B.1.617 and B.1.1.7, which was first..
Get Bharat Biotech to share vaccine manufacturing tech with other WHO prequalified pharma cos: Ghulam Nabi Azad
Tauktae now ‘very severe’ cyclone, set to rip into Gujarat at 185kmphCovid-bruised Gujarat braced for a battering by the strongest cyclone to hit its coast since 1998 as Tauktae, which cut a swathe through the western coastal belt..
Study: Covid deaths have affected 82% of elderly with anxietyLoneliness and a deepening sense of uncertainty has hit the senior citizens like never before during the second wave of Covid-19 pandemic, according to the..
‘PM Cares helped triple number of ventilators’Ventilators allocated to states and Union Territories under PM Cares and the health ministry have more than tripled availability of the critical care machines in..
Beat 1st wave, halted 2nd, ready to face 3rd: Yogi AdityanathUttar Pradesh CM Yogi Adityanath asserted here on Sunday that the country’s largest state was able to arrest the second surge of Covid-19 and was prepared to..
Rs 23,000 crore given to state disaster fund, 50% of it for Covid fightThe Centre has allocated over Rs 23,000 crore towards State Disaster Response Fund (SDRF) for the second successive year in 2021-22, half of which has been..
Rajnath Singh to release first batch of DRDO's anti-COVID oral drug 2DG todayDeveloped by DRDO's INMAS, in collaboration with Dr Reddy's Laboratories in Hyderabad, the 2DG drug is an anti-Covid therapeutic application.
Second batch of Russian Covid-19 vaccine Sputnik V reaches HyderabadAs the second batch of the Sputnik V landed in Hyderabad, Telangana on Sunday, Russian Ambassador to India, Nikolay Kudashev termed the Russian-Indian fight..
Second batch of Russian Covid-19 vaccine Sputnik V arrives in HyderabadAs the second batch of the Sputnik V landed in Hyderabad, Telangana on Sunday, Russian Ambassador to India, Nikolay Kudashev termed the Russian-Indian fight..
Dr Reddy's rolls out Sputnik V Covid-19 vaccine in India at around Rs 995 per doseDr Reddy’s Laboratories, the Indian partner of Russian Direct Investment Fund (RDIF), said it has commenced Sputnik V’s India rollout with the first dose..
Covid-19: Dr Reddy's rolls out Sputnik V in India at around Rs 995 per doseDr Reddy’s Laboratories, the Indian partner of Russian Direct Investment Fund (RDIF), said it has commenced Sputnik V’s India rollout with the first dose..
India's Covid cases fall but deaths remain high; fatality rate rises in MayDaily cases of Covid-19 in India continued to fall after hitting a peak last week but deaths remained high with close to 4,000 fatalities recorded on Thursday...
50 Floor | Morning Blend
Credit: ABC Action News Duration: 03:45Published
Spring Reboot | Morning Blend
Credit: ABC Action News Duration: 05:11Published
Counsel's Corner | Morning Blend
Credit: ABC Action News Duration: 04:51Published
Related news from verified sources